A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.
作者信息
Hrabar A, Vodopija I, André F E, Mitchell J R, Maassab H F, Hennessy A V, Davenport F M